BAMCO INC /NY/ - BIOHAVEN PHARMACTL HLDG CO L ownership

BIOHAVEN PHARMACTL HLDG CO L's ticker is BHVN and the CUSIP is G11196105. A total of 191 filers reported holding BIOHAVEN PHARMACTL HLDG CO L in Q4 2019. The put-call ratio across all filers is 0.20 and the average weighting 0.8%.

Quarter-by-quarter ownership
BAMCO INC /NY/ ownership history of BIOHAVEN PHARMACTL HLDG CO L
ValueSharesWeighting
Q4 2021$27,284,000
+74.6%
197,980
+76.0%
0.06%
+65.7%
Q3 2021$15,630,000
+10.3%
112,517
-22.9%
0.04%
+9.4%
Q2 2021$14,174,000
+42.0%
146,0000.0%0.03%
+28.0%
Q1 2021$9,979,000
-26.6%
146,000
-8.0%
0.02%
-26.5%
Q4 2020$13,600,000
+35.6%
158,675
+2.9%
0.03%
+9.7%
Q3 2020$10,029,000
-9.4%
154,275
+1.9%
0.03%
-22.5%
Q2 2020$11,067,000
+114.9%
151,3750.0%0.04%
+60.0%
Q1 2020$5,151,000
+2101.3%
151,375
+3420.3%
0.02%
+2400.0%
Q4 2019$234,0004,3000.00%
Other shareholders
BIOHAVEN PHARMACTL HLDG CO L shareholders Q4 2019
NameSharesValueWeighting ↓
Knoll Capital Management, LLC 710,422$24,658,74716.62%
Birchview Capital, LP 7,365$255,6390.24%
Itau Unibanco Holding S.A. 88$3,0540.00%
View complete list of BIOHAVEN PHARMACTL HLDG CO L shareholders